Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned

This publication has 71 references indexed in Scilit:

• Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience
  Pediatrics, 2001
• Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural Infection
  Infection and Immunity, 2001
• Immunogenicity Issues in the Quality Control of the New Acellular Pertussis Vaccines
  Biologicals, 1999
• Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines
  Vaccine, 1999
• Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants
  The Journal of Pediatrics, 1996
• Acellular Pertussis Vaccine (Infanrix™-DTPa; SB-3)
  Drugs, 1996
• Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b - PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine
  European Journal of Pediatrics, 1996
• Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children
  European Journal of Pediatrics, 1993
• Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants
  The Journal of Pediatrics, 1991
• PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTS
  The Lancet, 1988